The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 08, 2019

Filed:

Mar. 16, 2015
Applicant:

University of Kansas, Lawrence, KS (US);

Inventors:

Mei He, Olathe, KS (US);

Yong Zeng, Olathe, KS (US);

Andrew Godwin, Leawood, KS (US);

Assignee:

University of Kansas, Lawrence, KS (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
B01L 3/00 (2006.01); G01N 33/53 (2006.01); G01N 33/543 (2006.01); G01N 33/574 (2006.01);
U.S. Cl.
CPC ...
B01L 3/502761 (2013.01); G01N 33/5304 (2013.01); G01N 33/54366 (2013.01); G01N 33/54386 (2013.01); G01N 33/57488 (2013.01); B01L 2200/0668 (2013.01); B01L 2300/087 (2013.01); B01L 2300/0816 (2013.01); B01L 2300/0883 (2013.01); B01L 2400/043 (2013.01); B01L 2400/0487 (2013.01); G01N 2333/4725 (2013.01); G01N 2333/4745 (2013.01); G01N 2333/70596 (2013.01); G01N 2800/52 (2013.01);
Abstract

A microfluidic exosome profiling platform integrating exosome isolation and targeted proteomic analysis is disclosed. This platform is capable of quantitative exosomal biomarker profiling directly from 30 μL plasma samples within approximately 100 minutes with markedly enhanced sensitivity and specificity. Identification of distinct subpopulation of patient-derived exosomes is demonstrated by probing surface proteins and multiparameter analyses of intravesicular biomarkers in the selected subpopulation. The expression of IGF-1R and its phosphorylation level in non-small cell lung cancer (NSCLC) patient plasma is assessed, as a non-invasive alternative to the conventional biopsy and immunohistochemistry. The microfluidic chip, which may be fabricated of a glass substrate and a layer of poly(dimethylsiloxane), can include a first capture chamber, a second capture chamber, a serpentine microchannel, a first microchannel, a second microchannel, a sample inlet, a buffer inlet, a bead inlet, at least a first connector channel, and a reagent inlet.


Find Patent Forward Citations

Loading…